Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction

Yu Horiuchi, Nicholas Wettersten, Mitul P. Patel, Christian Mueller, Sean Xavier Neath, Robert H. Christenson, Nils G. Morgenthaler, James Mccord, Richard M. Nowak, Gary M. Vilke, Lori B. Daniels, Judd E. Hollander, Fred S. Apple, Chad M. Cannon, John T. Nagurney, Donald Schreiber, Christopher Defilippi, Christopher Hogan, Deborah B. Diercks, Gary HeaddenAlexander T. Limkakeng, Inder Anand, Alan H.B. Wu, Stefan Ebmeyer, Allan S. Jaffe, W. Frank Peacock, Alan Maisel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences